Home / Going-concern warnings / Cellectar Biosciences, Inc.
Filed 2025-08-14 路 Form 10-Q 路 Accession 0001410578-25-001778 nano
Price before filing: $4.42 (2025-08-13 close, split/dividend-adjusted)
Market cap at flag: $5.6M (2025-08-14) 路 Latest: $13.9M (2026-10-16)
| Window | CLRB | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +16.5% | +2.5% | +14.0% | 2025-09-15 |
| 90 days | -20.8% | +6.3% | -27.1% | 2025-11-12 |
| 180 days | -24.4% | +7.9% | -32.4% | 2026-02-10 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 3 insiders bought $125K (3 purchases)
30 days after: none reported.
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2025-07-02 | CARUSO JAMES V Chief Executive Officer, Director | Purchase | 10,000 | $4.99 | $50K | no | Form 4 |
| 2025-07-02 | Kolean Chad J Chief Financial Officer | Purchase | 5,000 | $4.99 | $25K | no | Form 4 |
| 2025-07-02 | Longcor Jarrod Chief Operating Officer | Purchase | 10,000 | $4.99 | $50K | no | Form 4 |
| 2025-08-14: red flag filed | |||||||
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-05-16 to 2025-09-13. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"These uncertainties raise substantial doubt about the Company's ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2025-06-30)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.